Mirvetuximab soravtansine Antibody

SKU: orb2279099

Description

Mirvetuximab soravtansine (IMGN853) is an antibody-drug conjugate (ADC) targeting folate receptor alpha (FRα) for cancer research. It delivers a cytotoxic payload to inhibit proliferation and has demonstrated activity in preclinical models of ovarian cancer, including studies involving drug-resistant cell lines and xenograft models.

Research Area

Cell Biology

Images & Validation

−

Key Properties

−

Target	Antifolate
Molecular Weight	150000 (average)
Purity	95.52% (May vary between batches)
Conjugation	Unconjugated

Storage & Handling

−

Storage	Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Concentration	5.2 mg/mL
Expiration Date	12 months from date of receipt.
Disclaimer	For research use only

Alternative Names

−

Mirvetuximab soravtansine, IMGN 853, IMGN853, IMGN-853, FRα, TAK-853

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Compound Identifiers

PubChem CID

5715188 ↗

Key Properties

−

No computed properties available.

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

Find More Protocols